Inventor · disambiguated record
Manuel Schmidt
Also filed as: SCHMIDT MANUEL
11 granted patents·7 pending applications·69 citations·filing 2005–2023
89Inventor score
Top patents by PatentIndex Score
18 records- 0190US10604760B2Combination comprising immunostimulatory oligonucleotidesMOLOGEN AG·Filed 2019·Granted Mar 31, 2020·5 cites·1 claims
- 0290US10487333B2Combination comprising immunostimulatory oligonucleotidesMOLOGEN AG·Filed 2016·Granted Nov 26, 2019·7 cites·3 claims
- 0386US8017591B2Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animalsMOLOGEN AG·Filed 2006·Granted Sep 13, 2011·13 cites·11 claims
- 0485US7635468B2Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccineMOLOGEN AG·Filed 2006·Granted Dec 22, 2009·13 cites·4 claims
- 0584US9212366B2Immune modulating oligonucleotides in connection with chemotherapeutic measuresWITTIG BURGHARDT·Filed 2005·Granted Dec 15, 2015·9 cites·8 claims
- 0683US9499815B1Multimer for immunostimulationSCHROFF MATTHIAS·Filed 2007·Granted Nov 22, 2016·12 cites·9 claims
- 0777US10006032B2Predictive biomarker for cancer therapyMOLOGEN AG·Filed 2014·Granted Jun 26, 2018·4 cites·6 claims
- 0874US9345754B2Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccineDOBRIC TOMISLAV·Filed 2009·Granted May 24, 2016·4 cites·20 claims
- 0968US9375435B2Use of a DNA expression constructWALTHER WOLFGANG·Filed 2011·Granted Jun 28, 2016·2 cites·7 claims
- 1067US11578331B2Combination comprising immunostimulatory oligonucleotidesGILEAD SCIENCES INC·Filed 2020·Granted Feb 14, 2023·0 cites·4 claims
- 1163US2023310594A1Methods of treating a latent hiv-1 infection using non-coding deoxyribonucleic acidsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 1257US2021155933A1Tlr-9 agonists for modulation of tumor microenvironmentGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 1357US2021079403A1Tlr-9 agonists for modulation of tumor microenvironmentMOLOGEN AG·Filed 2018·Application pending·0 cites
- 1449US11583581B2Methods of treating a retroviral infectionGILEAD SCIENCES INC·Filed 2016·Granted Feb 21, 2023·0 cites·7 claims
- 1546US2020385732A1Biomarker for small cell lung cancer therapyMOLOGEN AG·Filed 2018·Application pending·0 cites
- 1644US2010303803A1Catenate for immunostimulationMOLOGEN AG·Filed 2008·Application pending·0 cites
- 1744US2009220931A1Functional in vitro immunoassayMOLOGEN AG·Filed 2006·Application pending·0 cites
- 1829US2012093804A1Concatamers for ImmunemodulationSCHROFF MATTHIAS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manuel Schmidt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →